Latest news
Loading news…
Regeneron
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Tarrytown, New York, United States Founded 1988 10001+ employees For Profit
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
4
Investments
13
6 exits
Monthly Visits
Available in Pro Contacts
9,998
Ticker
REGN
NASDAQ
Patents
2,609
304 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- REGN
- Exchange
- NASDAQ
- IPO date
- Apr 12, 1991
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 136
- Mobile apps
- 3
- Downloads (30d)
- 2
- Active products
- 30
- Patents granted
- 2,609
- Trademarks
- 304
- Top patent class
- Organic Chemistry
- IT spend
- $311.29M
Investor Activity
- Investments
- 13
- Lead investments
- 7
- Portfolio orgs
- 13
- Diversity investments
- 5
- Exits
- 6
- Exits via IPO
- 5
Company Info
- Founded
- 1988
- Employees
- 10001+
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 3
- Sub-organizations
- 1
- News articles
- 2,304
- Events
- 2
- HQ
- Tarrytown, New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Exit date
- Apr 12, 1991
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- 0
- Trend (30d)
- -1.4
- Trend (90d)
- 0.8
- Last layoff mention
- Jan 2, 2020
Investments by Regeneron
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Regeneron
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Regeneron
President, Chief Scientific Office & co-Founder
Associate Director
Founder, President, and Chief Executive Officer
Vice President
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
Senior Vice President, CHRO
Director Post Marketing Operations
V.P., Regeneron Pharmaceuticals - Chief Business and Admin. Officer, Regeneron Genetics Center
Vice President, Deputy Chief Compliance Officer
SVP Functional Genomics and Chief of VelociGene Operations
Senior Vice President, Research and Development Operations
Executive Vice President, General Counsel and Secretary
Senior Vice President, Head Development Operations & Portfolio Management
Sr Director
Scientist and Associate Director
Scientist
Executive Director, HR Technology & HR Operations
Director and Customer Insights & Market Access
Executive Vice President and General Manager, Industrial Operations and Product Supply
Senior Staff Engineer
Vice President, Head of Oncology Business Development
Senior Vice President, Regulatory Affairs
Senior Vice President
Executive Director, RGC, Regeneron Pharmaceuticals
9,998
professional contacts at Regeneron
Contact execs at Regeneron →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Regeneron
Loading news…
FAQs about Regeneron
People who checked this page also checked these
Sectors Regeneron invests & acquires in
Browse the full Acquirezy directory.